Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Farxiga (dapagliflozin) and Glyburide (Glynase) are both medications used to manage Type 2 diabetes. Both help lower your blood sugar (glucose), but they have several differences between them. Farxiga works by causing your kidneys to remove excess sugar through urine. It also has benefits for people with heart failure and chronic kidney disease (CKD). Glyburide, on the other hand, sends signals to your pancreas to release more insulin. Farxiga is typically taken once daily and is only available as a brand medication, while Glyburide can be taken once or twice daily and is available in both generic and brand forms. Farxiga has a lower risk of causing low blood sugar compared to Glyburide. Additionally, Farxiga isn't recommended during the second and third trimesters of pregnancy, whereas Glyburide's safety during pregnancy is not well-studied.
Farxiga (dapagliflozin)
Glyburide
Farxiga (dapagliflozin)
Glyburide
Summary of Farxiga vs. Glyburide
Summary for SGLT2 inhibitor
Prescription only
Farxiga, the brand name for dapagliflozin, is used together with a nutritious diet and exercise plan to lower blood sugar levels in people 10 years and older with Type 2 diabetes. It can also help lower the risk of serious complications, hospitalization, and death in certain adults with heart failure or chronic kidney disease (CKD). Farxiga (dapagliflozin) belongs to the drug class called sodium-glucose cotransporter 2 (SGLT2) inhibitors. It's taken by mouth once a day. Some side effects include yeast infections, urinating more often, and weight loss.
Summary for Sulfonylurea
Prescription only
Glyburide is taken by mouth to lower blood sugar levels for people who have Type 2 diabetes. This medication isn't meant to be taken alone, but in addition to eating a healthy diet and engaging in regular exercise. Glyburide is typically taken once or twice daily, depending on your dose.
Indications of Farxiga vs. Glyburide
Indications for
•Type 2 diabetes (in addition to diet and exercise) in people age 10 and over
•Lowering the risk of hospitalization for heart failure in adults with Type 2 diabetes and heart disease
•Lowering the risk of hospitalization and death due to heart problems in people with heart failure
•Lowering the risk of worsening kidney problems, hospitalization for heart failure, and death due to heart problems in adults with chronic kidney disease (CKD)
Indications for
•Type 2 diabetes
Pros and Cons of Farxiga vs. Glyburide
Pros and Const for SGLT2 inhibitor
Pros
•Taken only once daily
•Low risk of causing low blood sugar when taken by itself